$9.920
+0.225 (+2.27%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting BCRX is Strong buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 20-Day simple moving average is 9.78, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $—, making it Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 60-Day simple moving average is 9.56, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $—, making it Buy.
Technical Analysis for BCRX
AI Technical BCRXAs of 2026-08-29, the technical board for BioCryst Pharmaceuticals, Inc. (BCRX) reads strong buy: 9 indicators are flashing buy, 0 are indicating sell, and 4 are neutral. Price at $9.92 sits above every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 53.954, MACD stands at 0.074 (Buy), Stochastic %K stands at 29.499, Stochastic %D stands at 32.538 and CCI stands at 23.552.
BCRX trades above the 60-day SMA (9.56) and above the 200-day SMA (8.53). Immediate resistance sits at Classic R1 10.12, then R2 10.44. Support sits at Classic S1 9.47, then S2 9.14.
BioCryst Pharmaceuticals, Inc. (BCRX) Support & Resistance Level
BioCryst Pharmaceuticals, Inc. (BCRX) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 53.954 |
| STOCHk_14_3_3 | 29.499 |
| STOCHd_14_3_3 | 32.538 |
| CCI_20 | 23.552 |
| AO_5_34 | 0.177 |
| MOM_10 | 0.220 |
| MACD_12_26_9 | 0.074 |
BioCryst Pharmaceuticals, Inc. (BCRX) Relative Strength Index (RSI_14) is 53.954, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Stochastic %K is 29.499, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Stochastic %D is 32.538, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) CCI_20 is 23.552, creating a Neutral signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Awesome Oscillator (AO) is 0.177, creating a Buy signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Momentum (MOM) is 0.220, creating a Buy signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Average Convergence Divergence (MACD) is 0.074, creating a Buy signal.
BioCryst Pharmaceuticals, Inc. (BCRX) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 9.828 | Buy |
| MA_10 | 9.793 | Buy |
| MA_20 | 9.782 | Buy |
| MA_60 | 9.560 | Buy |
| MA_200 | 8.526 | Buy |
| MA_250 | 8.297 | Buy |
BioCryst Pharmaceuticals, Inc. (BCRX) 5-Day simple moving average is 9.828, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 10-Day simple moving average is 9.793, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 20-Day simple moving average is 9.782, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 60-Day simple moving average is 9.560, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 200-Day simple moving average is 8.526, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
BioCryst Pharmaceuticals, Inc. (BCRX) 250-Day simple moving average is 8.297, while BioCryst Pharmaceuticals, Inc. (BCRX) share price is $, making it a Buy.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.